Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma
- PMID: 39514166
- DOI: 10.1007/s40291-024-00754-6
Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma
Abstract
Background: Diffuse midline glioma, H3 K27-altered (DMG) is a fatal tumour that arises in the midline structures of the brain. When located in the pons, it is more commonly referred to as diffuse intrinsic pontine glioma (DIPG). DMG/DIPG is usually diagnosed when children are < 10 years, and it has a median overall survival of < 12 months after diagnosis. Radiological imaging is still the gold standard for DIPG diagnosis while the use of biopsy procedures led to our knowledge on its biology, such as with the identification of the canonical histone H3K27M mutation. However, the need to improve survival encourages the development of non-invasive, fast and inexpensive assays on biofluids for optimizing molecular diagnoses in DMG/DIPG. Here, we propose a rapid, new, imaging and epigenetics-based approach to diagnose DMG/DIPG in the plasma of paediatric patients.
Methods: A total of 20 healthy children (mean age: 10.5 years) and 24 children diagnosed with DMG/DIPG (mean age: 8.5 years) were recruited. Individual histones (H2A, H2B, H3, H4, macroH2A1.1 and macroH2A1.2), histone dimers and nucleosomes were assayed in biofluids by means of a new advanced flow cytometry ImageStream(X)-adapted method.
Results: We report a significant increase in circulating histone dimers and tetramers (macroH2A1.1/H2B versus control: p value < 0.0001; macroH2A1.2/H2B versus control: p value < 0.0001; H2A/H2B versus control: p value < 0.0001; H3/H4 versus control: p value = 0.008; H2A/H2B/H3/H4 versus control: p value < 0.0001) and a significant downregulation of individual histones (H2B versus control: p value < 0.0001; H3 versus control: p value < 0.0001; H4 versus control: p value < 0.0001). Moreover, histones were also detectable in the cerebrospinal fluid (CSF) of patients with DMG/DIPG and in the supernatant of SF8628, OPBG-DIPG002 and OPBG-DIPG004 DMG/DIPG cell lines, with patterns mostly similar to each other, but distinct compared to blood plasma.
Conclusions: In summary, we identified circulating histone signatures able to detect the presence of DMG/DIPG in biofluids of children, using a rapid and non-invasive ImageStream(X)-based imaging technology, which may improve diagnosis and benefit the patients.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict of interest: All authors: D.B., L.L.P., J.F., D.K.T., S.D.B., M.R.B., A.A., A.M., J.C., T.M. and M.V. declare no competing financial interests. Ethics approval and consent to participate: The institutional review board of Bambino Gesù Children’s Hospital, IRCCS, Rome, approved the collection of blood samples for this research. All participants provided informed consent before study procedures. Consent for publication: All authors have reviewed and given consent to this submission of this manuscript. Availability of data and material: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Code availability: Not applicable. Funding: This research was funded by the Ministry of Health of the Czech Republic, grant nr. NU23-03-00318; and by the Ministry of Education and Science of Bulgaria under the National Scientific Programme ‘Excellent Research and People for the Development of European Science’ 2021 (VIHREN) of the Bulgarian National Science Fund, contract #KP-06-DV/4 from 15 December 2021. Author contributions: J.C. and M.V. conceptualized the study; D.B. carried out the methodology; D.B., J.F., D.K.T., L.L.P. and M.R.B. carried out formal analysis and investigation; M.V. carried out writing—original draft preparation; D.B., A.A. and M.V. carried out writing—review and editing; J.F., J.C. and M.V. carried out funding acquisition; J.C., A.A., T.M., M.V. supervised the study.
Similar articles
-
Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.Acta Neuropathol Commun. 2018 Nov 5;6(1):117. doi: 10.1186/s40478-018-0614-1. Acta Neuropathol Commun. 2018. PMID: 30396367 Free PMC article.
-
Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG.Acta Neuropathol Commun. 2020 Apr 23;8(1):57. doi: 10.1186/s40478-020-00930-9. Acta Neuropathol Commun. 2020. PMID: 32326973 Free PMC article.
-
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.Acta Neuropathol. 2015 Dec;130(6):815-27. doi: 10.1007/s00401-015-1478-0. Epub 2015 Sep 23. Acta Neuropathol. 2015. PMID: 26399631 Free PMC article.
-
H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions.Cells. 2024 Jun 28;13(13):1122. doi: 10.3390/cells13131122. Cells. 2024. PMID: 38994974 Free PMC article. Review.
-
Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.Cancer Metastasis Rev. 2023 Jun;42(2):367-388. doi: 10.1007/s10555-023-10105-2. Epub 2023 Apr 29. Cancer Metastasis Rev. 2023. PMID: 37119408 Free PMC article. Review.
Cited by
-
Histone variants: key regulators of inflammation in cell dedifferentiation and transdifferentiation.Front Immunol. 2025 Jun 27;16:1619100. doi: 10.3389/fimmu.2025.1619100. eCollection 2025. Front Immunol. 2025. PMID: 40655151 Free PMC article. Review.
References
-
- Jessa S, Blanchet-Cohen A, Krug B, Vladoiu M, Coutelier M, Faury D, et al. Stalled developmental programs at the root of pediatric brain tumors. Nat Genet. 2019;51:1702–13. https://doi.org/10.1038/s41588-019-0531-7 . - DOI - PubMed - PMC
-
- Baade PD, Youlden DR, Valery PC, Hassall T, Ward L, Green AC, et al. Trends in incidence of childhood cancer in Australia, 1983–2006. Br J Cancer. 2010;102:620–6. https://doi.org/10.1038/sj.bjc.6605503 . - DOI - PubMed - PMC
-
- Johnson KJ, Cullen J, Barnholtz-Sloan JS, Ostrom QT, Langer CE, Turner MC, et al. Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomark Prev. 2014;23:2716–36. https://doi.org/10.1158/1055-9965.EPI-14-0207 . - DOI
-
- Hargrave DR, Zacharoulis S. Pediatric CNS tumors: current treatment and future directions. Expert Rev Neurother. 2007;7:1029–42. https://doi.org/10.1586/14737175.7.8.1029 . - DOI - PubMed
-
- Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl). 2016;131:803–20. https://doi.org/10.1007/s00401-016-1545-1 . - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous